US to share some coronavirus technologies with World Health Organization
Under the plan, certain technologies currently being developed by the National Institutes of Health will be licensed to the WHO’s COVID-19 Technology Access Pool, the sources said. The technologies will also be sub-licensed to the United Nations-backed medicines patent pool.
The policy is not intended to apply to vaccines and treatments that have been developed by private companies and are currently on the US market, the people said.
The US should not share NIH-developed technology that was used by Moderna, the vaccine maker that worked closely with the US government in its messenger RNA vaccine. Foreign countries and developers have long demanded access to Moderna’s technology and know-how, saying it would allow them to more quickly replicate their own versions of Moderna’s vaccine.
Sharing the technologies behind NIH-designed coronavirus diagnostics, treatments and vaccines is intended to allow other countries and developers to replicate the manufacturing process. As a result, officials expect the decision to build up a global stockpile of supplies to fight the pandemic more quickly.
The Biden administration’s plan will be announced Thursday morning by Health and Human Services Secretary Xavier Becerra at an event he is hosting with foreign health ministers, the people said.
The WHO, dozens of foreign countries and public health advocates have spent nearly two years urging the United States and other wealthy countries to share technologies related to its coronavirus vaccines, diagnostics and therapeutics.
Spain announced in November 2021 that it would share the technology behind an anti-coronavirus antibody test with the WHO, the first major donation to the pool, known as C-TAP.
U.S. participation in the WHO pool could jump-start global donations of such technologies, officials and advocates said.
“The U.S. government is setting the tone for the relationship between countries and the pharmaceutical industry, and for this kind of global cooperation,” said Peter Maybarduk, who oversees the global medicine program at Public Citizen, an advocacy organization. interests. “And by taking public inventions and working with the WHO to make them available to humanity…it’s a clear and powerful demonstration of what governments can do.”